Nocturnal hemodialysis is associated with restoration of impaired endotlielial progenitor cell biology in end-stage renal disease

American Journal of Physiology - Renal Physiology

Volumn 289, Issue 4 58-4, 2005, Pages

  Chan, Christopher T ^a   Li, Shu Hong ^a   Verma, Subodh ^b  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Daily dialysis; Left ventricular mass; Nocturnal home hemodialysis; Uremia

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ERYTHROPOIETIN; UREA; VASODILATOR AGENT;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CAUSE OF DEATH; CELL FUNCTION; CELL REGENERATION; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOLOGY; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; FEMALE; HEART LEFT VENTRICLE MASS; HEMODIALYSIS; HUMAN; HUMAN CELL; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; NOCTURNAL HEMODIALYSIS; PRIORITY JOURNAL; STEM CELL; UREA NITROGEN BLOOD LEVEL; UREMIA;

EID: 24944573014     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00127.2005     Document Type: Article

References (49)

1. Aicher A, Heeschen C, Mildner-Rihm C, Urbich C, Ihling C, Technau-Ihling K, Zeiher AM, and Dimmeler S. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 9: 1370-1376, 2003.
2. Amann K and Ritz E. Cardiac disease in chronic uremia: pathophysiology. Adv Ren Replace Ther 4: 212-224, 1997.
3. Amar J, Vernier I, Rossignol E, Bongard V, Arnaud C, Conte JJ, Salvador M, and Chamontin B. Nocturnal blood pressure and 24-hour pulse pressure are potent indicators of mortality in hemodialysis patients. Kidney Int 57: 2485-2491, 2000.
4. Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N, Grunwald F, Aicher A, Urbich C, Martin H, Hoelzer D, Dimmeler S, and Zeiher AM. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106: 3009-3017, 2002.
5. Badorff C, Brandes RP, Popp R, Rupp S, Urbich C, Aicher A, Fleming I, Busse R, Zeiher AM, and Dimmeler S. Transdifferentiation of blood-derived human adult endothelial progenitor cells into function-ally active cardiomyocytes. Circulation 107: 1024-1032, 2003.
6. Chan C, Floras JS, Miller JA, and Pierratos A. Improvement in ejection fraction by nocturnal haemodialysis in end-stage renal failure patients with coexisting heart failure. Nephrol Dial Transplant 17: 1518-1521, 2002.
7. Chan CT, Floras JS, Miller JA, Richardson RM, and Pierratos A. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int 61: 2235-2239, 2002.
8. Chan CT, Hanly P, Gabor J, Picton P, Pierratos A, and Floras JS. Impact of nocturnal hemodialysis on the variability of heart rate and duration of hypoxemia during sleep. Kidney Int 65: 661-665, 2004.
9. Chan CT, Harvey PJ, Picton P, Pierratos A, Miller JA, and Floras JS. Short-term blood pressure, noradrenergic, and vascular effects of nocturnal home hemodialysis. Hypertension 42: 925-931, 2003.
10. Choi JH, Kim KL, Huh W, Kim B, Byun J, Suh W, Sung J, Jeon ES, Oh HY, and Kim DK. Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 24: 1246-1252, 2004.
11. Daugirdas JT, Greene T, Depner TA, Gotch FA, and Star RA. Relationship between apparent (single-pool) and true (double-pool) urea distribution volume. Kidney Int 56: 1928-1933, 1999.
12. Dayoub H, Achan V, Adimoolam S, Jacobi J, Stuehlinger MC, Wang BY, Tsao PS, Kimoto M, Vallance P, Patterson AJ, and Cooke JP. Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence. Circulation 108: 3042-3047, 2003.
13. Devereux RB and Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55: 613-618, 1977.
14. Eizawa T, Murakami Y, Matsui K, Takahashi M, Muroi K, Amemiya M, Takano R, Kusano E, Shimada K, and Ikeda U. Circulating endothelial progenitor cells are reduced in hemodialysis patients. Curr Med Res Opin 19: 627-633, 2003.
15. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, and Toto R. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347: 2010-2019, 2002.
16. Fathi R, Haluska B, Isbel N, Short L, and Marwick TH. The relative importance of vascular structure and function in predicting cardiovascular events. J Am Coll Cardiol 43: 616-623, 2004.
17. Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, and Barre PE. Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease. J Am Soc Nephrol 11: 912-916, 2000.
18. Freedman MH, Cattran DC, and Saunders EF. Anemia of chronic renal failure: inhibition of erythropoiesis by uremic serum. Nephron 35: 15-19, 1983.
19. Heeschen C, Aicher A, Lehmann R, Fichtlscherer S, Vasa M, Urbich C, Mildner-Rihm C, Martin H, Zeiher AM, and Dimmeler S. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102: 1340-1346, 2003.
20. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, and Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348: 593-600, 2003.
21. Jackson ICA, Majka SM, Wang H, Pocius J, Hartley CJ, Majesky MW, Entman ML, Michael LH, Hirschi KK, and Goodell MA. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 107: 1395-1402, 2001.
22. Jindal KK, Manuel A, and Goldstein MB. Percent reduction in blood urea concentration during hemodialysis (PRU). A simple and accurate method to estimate Kt/V urea. ASAIO Trans 33: 286-288, 1987.
23. Kawamoto A, Tkebuchava T, Yamaguchi J, Nishimura H, Yoon YS, Milliken C, Uchida S, Masuo O, Iwaguro H, Ma H, Hanley A, Silver M, Kearney M, Losordo DW, Isner JM, and Asahara T. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 107: 461-468, 2003.
24. Lindner A, Charra B, Sherrard DJ, and Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290: 697-701, 1974.
25. London GM, Guerin AP, Marchais SJ, Pannier B, Safar ME, Day M, and Metivier F. Cardiac and arterial interactions in end-stage renal disease. Kidney Int 50: 600-608, 1996.
26. Owen WF Jr, Lew NL, Liu Y, Lowrie EG, and Lazarus JM. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 329: 1001-1006, 1993.
27. Pannier B, Guerin AP, Marchais SJ, Metivier F, Safar ME, and London GM. Postischemic vasodilation, endothelial activation, and cardiovascular remodeling in end-stage renal disease. Kidney Int 57: 1091-1099, 2000.
28. Parfrey PS and Foley RN. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 10: 1606-1615, 1999.
29. Patterson C. The Ponzo effect: endothelial progenitor cells appear on the horizon. Circulation 107: 2995-2997, 2003.
30. Pierratos A, Ouwendyk M, Francoeur R, Vas S, Raj DS, Ecclestone AM, Langos V, and Uldall R. Nocturnal hemodialysis: three-year experience. J Am Soc Nephrol 9: 859-868, 1998.
31. Ponassi A, Morra L, Gurreri G, Moccia F, Giusti M, Caristo G, and Sacchetti C. Alterations of granulopoiesis in chronic uremic patients treated with intermittent hemodialysis. Acta Haematol 77: 220-225, 1987.
32. Qureshi AR, Alvestrand A, Divino-Filho JC, Gutierrez A, Heimburger O, Lindholm B, and Bergstrom J. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol 13, Suppl 1: S28-S36, 2002.
33. Rauscher FM, Goldschmidt-Clermont PJ, Davis BH, Wang T, Gregg D, Ramaswami P, Pippen AM, Annex BH, Dong C, and Taylor DA. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 108: 457-463, 2003.
34. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, and Wilson PW. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108: 2154-2169, 2003.
35. Schwartz DI, Pierratos A, Richardson RM, Fenton SS, and Chan CT. Impact of nocturnal home hemodialysis oh anemia management in patients with end-stage renal disease. Clin Nephrol 63: 202-208, 2005.
36. Silvestre JS and Levy BI. Angiogenesis therapy in ischemic disease. Arch Mal Coeur Vaiss 95: 189-196, 2002.
37. Strauer BE, Brehm M, Zeus T, Kostering M, Hernandez A, Sorg RV, Kogler G, and Wernet P. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106: 1913-1918, 2002.
38. Szmitko PE, Fedak PW, Weisel RD, Stewart DJ, Kutryk MJ, and Verma S. Endothelial progenitor cells: new hope for a broken heart. Circulation 107: 3093-3100, 2003.
39. Vallance P, Leone A, Calver A, Collier J, and Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339: 572-575, 1992.
40. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, and Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89: E1-7, 2001.
41. Verma S, Kuliszewski MA, Li SH, Szmitko PE, Zucco L, Wang CH, Badiwala MV, Mickle DA, Weisel RD, Fedak PW, Stewart DJ, and Kutryk MJ. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation 109: 2058-2067, 2004.
42. Walter DH, Rittig K, Bahlmann FH, Kirchmair R, Silver M, Murayama T, Nishimura H, Losordo DW, Asahara T, and Isner JM. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 105: 3017-3024, 2002.
43. +-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo. Circulation 108: 2070-2073, 2003.
44. Yuen D, Richardson RMA, Fenton SSA, McGrath-Chong M, and Chan CT. Quotidian nocturnal hemodialysis improves cytokine profile and enhances erythropoietin responsiveness. ASAIO J 51: 236-241, 2005.
45. Zimmermann J, Herrlinger S, Pruy A, Metzger T, and Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55: 648-658, 1999.
46. Zoccali C, Benedetto FA, Maas R, Mallamaci F, Tripepi G, Malatino LS, and Boger R. Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease. J Am Soc Nephrol 13: 490-496, 2002.
47. Zoccali C, Mallamaci F, Maas R, Benedetto FA, Tripepi G, Malatino LS, Cataliotti A, Bellanuova I, and Boger R. Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients. Kidney Int 62: 339-345, 2002.
48. Zoccali C, Mallamaci F, and Tripepi G. Inflammation and atherosclerosis in end-stage renal disease. Blood Purif 21: 29-36, 2003.
49. Zoccali C, Mallamaci F, and Tripepi G. Traditional and emerging cardiovascular risk factors in end-stage renal disease. Kidney Int Suppl: 105-110, 2003.